Amal Therapeutics
Amal Therapeutics develops and commercializes peptide-based therapeutic vaccines for the treatment of cancer.
Business Model:
Revenue: $150M
Employees: 51-200
Industries / Tags:
Detailed Amal Therapeutics Information
Amal Therapeutics was acquired by
Boehringer Ingelheim.
The acquisition happend on 2019-07-15.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 64 av. of the Roseraie
City: Geneva
State: geneva
Zip: 1205
Country: CH
Financial Info
Stage:
series b
Raised Last:
$33M
Raised Total:$37M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Amal Therapeutics develops and commercializes peptide-based therapeutic vaccines for the treatment of cancer.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
